Bridge Biotherapeutics Announces a Successful Activation of U.S. Clinical Trial Sites for BBT-401 Phase 2 Study
SEONGNAM, South Korea, Dec. 27…
Thailand Board of Investment Pushes Thai GDP Growth by Over Bt400 Billion
BANGKOK, Dec. 28, 2018 /PRNews…
Exosystems to Demo Gamified Physical Therapy Technology at CES 2019
Korea-based healthcare firm Ex…
China’s NMPA Approves Innovent’s Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) for Hodgkin’s Lymphoma
SUZHOU, China, Dec. 27, 2018 /…
Merck Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
DARMSTADT, Germany, Dec. 20, 2…
WeDoctor Greater Bay Area Healthcare Platform Shenzhen Base Officially Opens
Enables Hong Kong Residents to…
CooTek Enhances Cherry, Its Feminine Care App, with a Daily User Health Report
MOUNTAIN VIEW, Calif., Dec. 24…
Focusing on CRO & CMO Industry Upgrading, ICSE China 2019 Helps Enterprises Seize New Industry Opportunities
SHANGHAI, Dec. 25, 2018 /PRNew…
CStone Pharmaceuticals announces initiation of CS1001 Phase I Study in U.S., patient enrollment under way
SUZHOU, China, Dec. 21, 2018 /…
I-Mab Receives U.S. FDA IND Approval for Proprietary Anti-GM-CSF Monoclonal Antibody TJM2
— The first I-Mab propri…
